This article provides researchers, scientists, and drug development professionals with a current and exhaustive framework for validating gene function using CRISPR knockout (KO) technologies.
This article provides a comprehensive analysis for researchers and drug development professionals on the pivotal shift from the foundational Cre-Lox system to the novel Programmable Chromosome Engineering (PCE) platforms.
This article provides a comprehensive comparison of two leading precision genome editing technologies: base editing and prime editing.
This article provides a definitive comparison of viral and non-viral methods for delivering the CRISPR/Cas9 system, tailored for researchers and drug development professionals.
This article provides a comprehensive analysis of the editing efficiency and specificity of diverse CRISPR-Cas protein variants, tailored for researchers and drug development professionals.
This article provides researchers, scientists, and drug development professionals with a definitive guide to validating CRISPR-Cas9 gene edits.
This article provides a detailed guide for researchers and drug development professionals on leveraging high-fidelity Cas variants to overcome the critical challenge of off-target effects in CRISPR genome editing.
The immunogenicity of the Cas9 nuclease presents a significant challenge for the clinical application of in vivo CRISPR-Cas9 therapies.
This article provides a comprehensive analysis of genetic mosaicism, a prevalent challenge that reduces the efficiency and reliability of CRISPR-based gene editing in both model organisms and therapeutic applications.
This article provides a comprehensive overview of the critical link between delivery methods and the accuracy of CRISPR-Cas9 gene editing in target cells, tailored for researchers and drug development professionals.